These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15576949)

  • 1. [Risk factors of atherosclerosis in end-stage renal disease patients].
    Jono S
    Clin Calcium; 2004 Jan; 14(1):21-6. PubMed ID: 15576949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular calcification: mechanisms and clinical ramifications.
    Abedin M; Tintut Y; Demer LL
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1161-70. PubMed ID: 15155384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special characteristics of atherosclerosis in chronic renal failure.
    Amann K; Tyralla K; Gross ML; Eifert T; Adamczak M; Ritz E
    Clin Nephrol; 2003 Jul; 60 Suppl 1():S13-21. PubMed ID: 12940530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular calcification in chronic kidney disease.
    Jono S; Shioi A; Ikari Y; Nishizawa Y
    J Bone Miner Metab; 2006; 24(2):176-81. PubMed ID: 16502129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study.
    Canfield AE; Farrington C; Dziobon MD; Boot-Handford RP; Heagerty AM; Kumar SN; Roberts IS
    J Pathol; 2002 Feb; 196(2):228-34. PubMed ID: 11793375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
    Ishimura E; Okuno S; Taniwaki H; Kizu A; Tsuchida T; Shioi A; Shoji T; Tabata T; Inaba M; Nishizawa Y
    Kidney Blood Press Res; 2008; 31(1):10-5. PubMed ID: 18097148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.
    Wang MC; Tsai WC; Chen JY; Huang JJ
    Am J Kidney Dis; 2005 Mar; 45(3):494-501. PubMed ID: 15754271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
    J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of vascular calcification].
    Kizu A; Jono S
    Clin Calcium; 2004 Jun; 14(6):92-6. PubMed ID: 15577061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of arterial calcification.
    Schinke T; McKee MD; Kiviranta R; Karsenty G
    Ann Med; 1998 Dec; 30(6):538-41. PubMed ID: 9920355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of calcification in blood and urine.
    Schlieper G; Westenfeld R; Brandenburg V; Ketteler M
    Semin Dial; 2007; 20(2):113-21. PubMed ID: 17374084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular calcification: lessons from scientific models.
    Sinha S; Eddington H; Kalra PA
    J Ren Care; 2009 Mar; 35 Suppl 1():51-6. PubMed ID: 19222732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arteriosclerosis and vascular calcification in chronic kidney disease (CKD) patients].
    Masho Y; Shigematsu T
    Clin Calcium; 2007 Mar; 17(3):354-9. PubMed ID: 17339739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular calcification in chronic kidney disease: pathogenesis and clinical implications.
    Shioi A; Nishizawa Y
    J Ren Nutr; 2009 Jan; 19(1):78-81. PubMed ID: 19121777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW; Jaff MR
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atherosclerosis and vascular calcification in hemodialysis patients].
    Hirasaka N; Liang XM; Mune M
    Clin Calcium; 2004 Jun; 14(6):85-90. PubMed ID: 15577060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal insufficiency is an important cardiovascular risk factor].
    Pérez Flores I; Luño J
    Nefrologia; 2002; 22(4):306-9. PubMed ID: 12369120
    [No Abstract]   [Full Text] [Related]  

  • 18. Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease.
    Betjes MG; Litjens NH; Zietse R
    Nephrol Dial Transplant; 2007 Nov; 22(11):3298-303. PubMed ID: 17597084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-138C polymorphism of matrix gla protein promoter alters its expression but is not directly associated with atherosclerotic vascular calcification.
    Kobayashi N; Kitazawa R; Maeda S; Schurgers L; Kitazawa S
    Kobe J Med Sci; 2004; 50(3-4):69-81. PubMed ID: 15864013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcified coronary artery disease and serum markers].
    Mori K; Jono S
    Clin Calcium; 2007 Mar; 17(3):340-5. PubMed ID: 17339737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.